<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00747331</url>
  </required_header>
  <id_info>
    <org_study_id>FenoldopamCPB</org_study_id>
    <nct_id>NCT00747331</nct_id>
  </id_info>
  <brief_title>Fenoldopam and Splanchnic Perfusion During Cardiopulmonary Bypass</brief_title>
  <official_title>Fenoldopam Prophylaxis of Splanchnic Organs Underperfusion During Cardiopulmonary Bypass: a Randomized, Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Policlinico S. Donato</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Policlinico S. Donato</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiopulmonary bypass (CPB) for cardiac operations may be accompanied by different patterns
      of visceral underperfusion. This could result in clinical patterns of lactic acidosis but in
      the most severe cases there is the risk for mesenteric infarction (0.2% of the cases). Renal
      function as well may be impaired due to a low oxygen delivery, and acute renal failure occurs
      in 1-2% of cases.

      Fenoldopam mesilate is a selective splanchnic vasodilator when used at a dose &lt; 0.1
      mcg/kg/min.

      The experimental hypothesis of this randomized, controlled trial (RCT) is that the use of
      fenoldopam may determine a better visceral perfusion during CPB.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized placebo-controlled double blinded study. Patients undergoing complex cardiac
      operations will be randomly allocated to the study or the control group.

      All the patients will receive the standard of care of our Institution. Adequacy of CPB
      perfusion will be assessed using oxygen delivery calculation, lactate production, SvO2.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peak blood lactate levels during CPB</measure>
    <time_frame>3 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urine output during CPB</measure>
    <time_frame>3 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak blood lactate levels during the postoperative period</measure>
    <time_frame>48 hours after the end of the operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak serum creatinine level during the postoperative period</measure>
    <time_frame>48 hours after the end of the operation</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cardiac Complications</condition>
  <condition>Cardiopulmonary Bypass</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fenoldopam mesilate</intervention_name>
    <description>Continuous intravenous infusion at 0.1 mcg/kg/min starting immediately before CPB and ending after 12 hours from the end of the operation</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Corlopam</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Intravenous infusion (saline)
Infused at the same rate (ml/h) as the experimental drug</description>
    <arm_group_label>B</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Complex, combined cardiac operation

          -  Predicted CPB duration &gt; 90 minutes

        Exclusion Criteria:

          -  Age &lt; 18 years

          -  No written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco Ranucci, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>IRCCS Policlinico S. Donato</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IRCCS Policlinico S.Donato</name>
      <address>
        <city>San donato Milanese</city>
        <state>Milan</state>
        <zip>20097</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Ranucci M, Soro G, Barzaghi N, Locatelli A, Giordano G, Vavassori A, Manzato A, Melchiorri C, Bove T, Juliano G, Uslenghi MF. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients. Ann Thorac Surg. 2004 Oct;78(4):1332-7; discussion 1337-8.</citation>
    <PMID>15464494</PMID>
  </reference>
  <verification_date>April 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2008</study_first_submitted>
  <study_first_submitted_qc>September 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2008</study_first_posted>
  <last_update_submitted>April 10, 2009</last_update_submitted>
  <last_update_submitted_qc>April 10, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 13, 2009</last_update_posted>
  <responsible_party>
    <name_title>Marco Ranucci, M.D.</name_title>
    <organization>IRCCS Policlinico S.Donato</organization>
  </responsible_party>
  <keyword>Cardiopulmonary bypass</keyword>
  <keyword>Lactic acidosis</keyword>
  <keyword>Oxygen delivery</keyword>
  <keyword>Acute renal failure</keyword>
  <keyword>outcome</keyword>
  <keyword>cardiac</keyword>
  <keyword>surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fenoldopam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

